Scientific Poster , First-in-Human

BPS 2022 Poster: A Phase 1 Randomized PK Study of Amilo-5MER

22 September 2022
  • Home
  • Resources
  • BPS 2022 Poster: A Phase 1 Randomized PK Study of Amilo-5MER
Overview

A Phase 1, Randomized, Double-Blind, Placebo Controlled, First-in-Human Study to Assess Safety, Tolerability & Pharmacokinetics (PK) of Amilo-5MER in Healthy Volunteers

Download
Date
22 September 2022